Elsevier

Neurobiology of Aging

Volume 17, Issue 6, November–December 1996, Pages 843-848
Neurobiology of Aging

Cytochrome c oxidase defects of the human substantia nigra in normal aging

https://doi.org/10.1016/S0197-4580(96)00168-6Get rights and content

Abstract

Based on morphological, biochemical, and molecular biologic analyses, degeneration of the dopaminergic nigrostriatal system has been reported to occur with normal aging. In the present study, the substantia nigra of 36 human brains with normal aging was investigated by means of morphometry and immunohistochemistry. The anteromedial (Am), anterointermediolateral (Ail), posteromedial (Pm), and posterolateral (Pl) nuclei of the substantia nigra were analyzed using antibodies directed against the subunits II/III of cytochrome c oxidase (COX), the complex IV of the respiratory chain. The numerical density of melanin-positive neurons with COX defects was significantly increased in the four investigated nuclei, namely Am, Ail, Pm, and Pl. These cells did not show any histologic signs of degeneration. The numerical density of melanin-positive neurons without COX defects was decreased with aging. The data of the present study indicate that complex IV defects of neurons in the substantia nigra might be one cause of neuronal dysfunction occurring during aging.

References (43)

  • B.A. Sabel et al.

    Extensive loss of subcortical neurons in the aging rat brain

    Exp. Neurol.

    (1981)
  • E.A. Shoubridge et al.

    Deletion mutants are functionally dominant over wild-type mitochondrial genomes in skeletal muscle fibre segments in mitochondrial disease

    Cell

    (1990)
  • S. Sugiyama et al.

    Quantitative analysis of age-matched accumulation of mitochondrial DNA with deletion in human hearts

    Biochem. Biophys. Res. Commun.

    (1991)
  • I. Trounce et al.

    Decline in skeletal muscle mitochondrial respiratory chain function: Possible factor in aging

    Lancet

    (1989)
  • T.-C. Yen et al.

    Ageing-associated 5 kb deletion in human liver mitochondrial DNA

    Biochem. Biophys. Res. Commun.

    (1991)
  • M. Corral-Debrinski et al.

    Mitochondrial DNA deletions in human brain: Regional variability and increase with advanced age

    Nat. Genet.

    (1992)
  • S. DiMauro et al.

    Mitochondrial DNA in human pathology

    (1993)
  • D.A. Evans et al.

    Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported

    JAMA

    (1989)
  • J.M. Fearnley et al.

    Aging and Parkinson's disease: Substantia nigra regional selectivity

    Brain

    (1991)
  • D.L. Felton et al.

    Chronic dietary pergolide preserves nigrostriatal neuronal integrity in aged Fischer 344 rats

    Neurobiol. Aging

    (1992)
  • D.L. Felton et al.

    Age-related decline in the dopaminergic nigrostriatal system: The oxidative hypothesis and protective strategies

    Ann. Neurol. Suppl.

    (1992)
  • Cited by (62)

    • Ultradeep mapping of neuronal mitochondrial deletions in Parkinson's disease

      2018, Neurobiology of Aging
      Citation Excerpt :

      Somatic mitochondrial DNA (mtDNA) mutations accumulate in postmitotic cell populations with increasing age and, if high enough levels are reached, can cause dysfunction of the respiratory chain (Bua et al., 2006; Itoh et al., 1996; Sciacco et al., 1994).

    • Mitochondrial DNA mutations in neurodegeneration

      2015, Biochimica et Biophysica Acta - Bioenergetics
      Citation Excerpt :

      A further analysis by combining data from 10 previous PD studies also showed independent protective effects for haplogroups J, K and T, and an increased risk of disease for super-haplogroup HV (p = 3.63 × 10− 3, OR = 1.112), though the mechanism remains unclear [105]. The observation of a mosaic pattern of respiratory chain deficiency in human PD post-mortem brain tissue [107] further supported the hypothesis that mitochondrial DNA mutations may be implicated in respiratory chain impairment in PD. In 2006 Bender et al. confirmed that PD patients had a greater proportion of COX deficient neurons in the substantia nigra than controls (~ 3% vs 1%, p = 0.003) [3], and although mtDNA deletion levels in both PD and controls was high in SN tissue homogenates (52.3% ± 9.3% vs 43.3% ± 9.3%) this did not reach statistical significance (p = 0.06).

    • Ageing and Parkinson's disease: Why is advancing age the biggest risk factor?

      2014, Ageing Research Reviews
      Citation Excerpt :

      Respiratory deficiency can be defined as a decline in the activity of complex IV which can be visualised in tissue using the COX/SDH assay. Bender et al. report that approximately 3% of SN neurons are COX deficient in patients with PD compared to 1% in age matched controls, while other studies have reported up to 30% COX deficiency in some cases (Bender et al., 2006; Itoh et al., 1996; Kraytsberg et al., 2006). Furthermore, Elson et al. predicted that 1–4% of post mitotic cells in 80–120 year olds would be COX deficient and that this accumulation would begin from the age of 60 (Elson et al., 2001).

    • Convergent evidence for abnormal striatal synaptic plasticity in dystonia

      2010, Neurobiology of Disease
      Citation Excerpt :

      DA's influence in dystonia is varied, complex, and sometimes paradoxical. Despite some SNc DA cell loss with normal aging (Cruz-Sanchez et al., 1997; Itoh et al., 1996) and unlike Parkinson's disease, there is historically no evidence for abnormal cellular degeneration of nigral DA cells in dystonia. Nevertheless, reduced striatal DA (Perlmutter et al., 1997b; Tabbal et al., 2006), or more commonly a general DA dysfunction (Augood et al., 2004, 1999; Breakefield et al., 2008; Perlmutter and Mink, 2004), have been suggested as factors in dystonia (see also Wichmann (2008) for a recent review).

    View all citing articles on Scopus
    View full text